- Home
- Publications
- Publication Search
- Publication Details
Title
Biomarkers for Basal-like Breast Cancer
Authors
Keywords
-
Journal
Cancers
Volume 2, Issue 2, Pages 1040-1065
Publisher
MDPI AG
Online
2010-05-28
DOI
10.3390/cancers2021040
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Basal Cytokeratin Expression in Relation to Immunohistochemical and Clinical Characterization in Breast Cancer Patients with Triple Negative Phenotype
- (2018) Zhe-Bin Liu et al. TUMORI
- PARP inhibitors in BRCA1-/BRCA2-associated and triple-negative breast cancers
- (2010) Justin Stebbing et al. Future Oncology
- HOXA9 regulates BRCA1 expression to modulate human breast tumor phenotype
- (2010) Penney M. Gilbert et al. JOURNAL OF CLINICAL INVESTIGATION
- Efficacy of Neoadjuvant Cisplatin in Triple-Negative Breast Cancer
- (2010) Daniel P. Silver et al. JOURNAL OF CLINICAL ONCOLOGY
- Breast cancer molecular profiling with single sample predictors: a retrospective analysis
- (2010) Britta Weigelt et al. LANCET ONCOLOGY
- Ki67 in breast cancer: prognostic and predictive potential
- (2010) Rinat Yerushalmi et al. LANCET ONCOLOGY
- Stromal Cell Expression of Caveolin-1 Predicts Outcome in Breast Cancer
- (2009) Erica K. Sloan et al. AMERICAN JOURNAL OF PATHOLOGY
- Most Basal-like Breast Carcinomas Demonstrate the Same Rb−/p16+ Immunophenotype as the HPV-related Poorly Differentiated Squamous Cell Carcinomas Which They Resemble Morphologically
- (2009) Andrea Proctor Subhawong et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- The role of VEGF in triple-negative breast cancer: where do we go from here?
- (2009) S. F. Dent ANNALS OF ONCOLOGY
- Significantly higher levels of vascular endothelial growth factor (VEGF) and shorter survival times for patients with primary operable triple-negative breast cancer
- (2009) B. K. Linderholm et al. ANNALS OF ONCOLOGY
- Epidermal growth factor receptor inhibitors in cancer treatment: advances, challenges and opportunities
- (2009) Helmout Modjtahedi et al. ANTI-CANCER DRUGS
- Genomic and proteomic biomarkers for cancer: A multitude of opportunities
- (2009) Michael A. Tainsky BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- Nuclear detection of Y-boxprotein-1 (YB-1) closely associates with progesterone receptor negativity and is a strong adverse survival factor in human breast cancer
- (2009) Edgar Dahl et al. BMC CANCER
- Emergence of nonanthracycline regimens in the adjuvant treatment of breast cancer
- (2009) Sumanta K. Pal et al. BREAST CANCER RESEARCH AND TREATMENT
- Prognostic impact of ALDH1 in breast cancer: a story of stem cells and tumor microenvironment
- (2009) Erika Resetkova et al. BREAST CANCER RESEARCH AND TREATMENT
- BRCA1 transcriptionally regulates genes associated with the basal-like phenotype in breast cancer
- (2009) Julia J. Gorski et al. BREAST CANCER RESEARCH AND TREATMENT
- The proteins FABP7 and OATP2 are associated with the basal phenotype and patient outcome in human breast cancer
- (2009) H. Zhang et al. BREAST CANCER RESEARCH AND TREATMENT
- A validated gene expression profile for detecting clinical outcome in breast cancer using artificial neural networks
- (2009) L. J. Lancashire et al. BREAST CANCER RESEARCH AND TREATMENT
- Aquaporin 1 (AQP1) expression is a novel characteristic feature of a particularly aggressive subgroup of basal-like breast carcinomas
- (2009) Friedrich Otterbach et al. BREAST CANCER RESEARCH AND TREATMENT
- CD44 is overexpressed in basal-like breast cancers but is not a driver of 11p13 amplification
- (2009) Pamela Klingbeil et al. BREAST CANCER RESEARCH AND TREATMENT
- Overexpression of E2F-5 correlates with a pathological basal phenotype and a worse clinical outcome
- (2009) S Umemura et al. BRITISH JOURNAL OF CANCER
- Expression of aldehyde dehydrogenase 1 (ALDH1) is associated with basal-like markers and features of aggressive tumours in African breast cancer
- (2009) H Nalwoga et al. BRITISH JOURNAL OF CANCER
- The key hypoxia regulated gene CAIX is upregulated in basal-like breast tumours and is associated with resistance to chemotherapy
- (2009) E Y Tan et al. BRITISH JOURNAL OF CANCER
- High Frequency of TP53 Mutation in BRCA1 and Sporadic Basal-like Carcinomas but not in BRCA1 Luminal Breast Tumors
- (2009) E. Manie et al. CANCER RESEARCH
- Basal and Triple-Negative Breast Cancers: Impact on Clinical Decision-Making and Novel Therapeutic Options
- (2009) David Voduc et al. Clinical Breast Cancer
- A New Immunostain Algorithm Classifies Diffuse Large B-Cell Lymphoma into Molecular Subtypes with High Accuracy
- (2009) W. W.L. Choi et al. CLINICAL CANCER RESEARCH
- Triple-Negative Breast Cancer: Distinguishing between Basal and Nonbasal Subtypes
- (2009) E. A. Rakha et al. CLINICAL CANCER RESEARCH
- Cell-to-cell contact and extracellular matrix
- (2009) Martin J. Humphries et al. CURRENT OPINION IN CELL BIOLOGY
- Molecular Classification of Breast Carcinomas by Immunohistochemical Analysis
- (2009) Ping Tang et al. DIAGNOSTIC MOLECULAR PATHOLOGY
- Triple-negative breast cancer: current management and future options
- (2009) PierFranco Conte et al. EJC SUPPLEMENTS
- Clinical relevance of the triple-negative breast cancer concept: Genetic basis and clinical utility of the concept
- (2009) Sabine C. Linn et al. EUROPEAN JOURNAL OF CANCER
- IMP3 is a novel biomarker for triple negative invasive mammary carcinoma associated with a more aggressive phenotype
- (2009) Otto Walter et al. HUMAN PATHOLOGY
- Elevated expression of phosphorylated c-Jun NH2-terminal kinase in basal-like and “triple-negative” breast cancers
- (2009) Xiao Wang et al. HUMAN PATHOLOGY
- p53 as a Specific Prognostic Factor in Triple-negative Breast Cancer
- (2009) B. J. Chae et al. JAPANESE JOURNAL OF CLINICAL ONCOLOGY
- Prognostic Significance of Basal Markers in Triple-negative Breast Cancers
- (2009) Jun Mo Kim et al. Journal of Breast Cancer
- Supervised Risk Predictor of Breast Cancer Based on Intrinsic Subtypes
- (2009) Joel S. Parker et al. JOURNAL OF CLINICAL ONCOLOGY
- Alpha6beta4 integrin crosslinking induces EGFR clustering and promotes EGF-mediated Rho activation in breast cancer
- (2009) Michael Z Gilcrease et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Does vimentin help to delineate the so-called 'basal type breast cancer'?
- (2009) Renata U Kusinska et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Triple-negative breast cancer: clinicopathological characteristics and relationship with basal-like breast cancer
- (2009) Aye Aye Thike et al. MODERN PATHOLOGY
- Motility Induction in Breast Carcinoma by Mammary Epithelial Laminin 332 (Laminin 5)
- (2009) P. M. Carpenter et al. MOLECULAR CANCER RESEARCH
- A Novel Tumor-Targeted Therapy Using a Claudin-4-Targeting Molecule
- (2009) R. Saeki et al. MOLECULAR PHARMACOLOGY
- Aberrant luminal progenitors as the candidate target population for basal tumor development in BRCA1 mutation carriers
- (2009) Elgene Lim et al. NATURE MEDICINE
- Gene-Expression Signatures in Breast Cancer
- (2009) Christos Sotiriou et al. NEW ENGLAND JOURNAL OF MEDICINE
- Expression of Tight Junction Protein Claudin-4 in Basal-Like Breast Carcinomas
- (2009) Janina Kulka et al. PATHOLOGY & ONCOLOGY RESEARCH
- Overexpression of fatty acid binding protein-7 correlates with basal-like subtype of breast cancer
- (2009) Xiao Yan Tang et al. PATHOLOGY RESEARCH AND PRACTICE
- Met induces diverse mammary carcinomas in mice and is associated with human basal breast cancer
- (2009) C. R. Graveel et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Claudins 1, 3, and 4 protein expression in ER negative breast cancer correlates with markers of the basal phenotype
- (2009) Anne A. Blanchard et al. VIRCHOWS ARCHIV
- Anti-EGFR Therapy: Mechanism and Advances in Clinical Efficacy in Breast Cancer
- (2009) John F. Flynn et al. Journal of Oncology
- A comparison between p53 accumulation determined by immunohistochemistry andTP53mutations as prognostic variables in tumours from breast cancer patients
- (2008) Jan Alsner et al. ACTA ONCOLOGICA
- Expression of EGFR and c-kit is associated with the basal-like phenotype in breast carcinomas of African women
- (2008) HAWA NALWOGA et al. APMIS
- Gene expression predicts overall survival in paraffin-embedded tissues of diffuse large B-cell lymphoma treated with R-CHOP
- (2008) L. M. Rimsza et al. BLOOD
- Patho-biological aspects of basal-like breast cancer
- (2008) Emad A. Rakha et al. BREAST CANCER RESEARCH AND TREATMENT
- Invasive ductal carcinoma of the breast with the “triple-negative” phenotype: prognostic implications of EGFR immunoreactivity
- (2008) Giuseppe Viale et al. BREAST CANCER RESEARCH AND TREATMENT
- Efficacy and safety of erlotinib in patients with locally advanced or metastatic breast cancer
- (2008) Maura N. Dickler et al. BREAST CANCER RESEARCH AND TREATMENT
- Caveolin 1 and Caveolin 2 are associated with breast cancer basal-like and triple-negative immunophenotype
- (2008) S E Elsheikh et al. BRITISH JOURNAL OF CANCER
- Biomarkers of apoptosis
- (2008) T H Ward et al. BRITISH JOURNAL OF CANCER
- Tumoral Angiogenesis: Review of the Literature
- (2008) Parham Khosravi Shahi et al. CANCER INVESTIGATION
- Therapeutic Strategies for Triple-Negative Breast Cancer
- (2008) Antoinette R. Tan et al. CANCER JOURNAL
- Epithelial-Mesenchymal Transition in Breast Cancer Relates to the Basal-like Phenotype
- (2008) D. Sarrio et al. CANCER RESEARCH
- Analysis of Integrin 4 Expression in Human Breast Cancer: Association with Basal-like Tumors and Prognostic Significance
- (2008) S. Lu et al. CLINICAL CANCER RESEARCH
- Association of an Extracellular Matrix Gene Cluster with Breast Cancer Prognosis and Endocrine Therapy Response
- (2008) J. Helleman et al. CLINICAL CANCER RESEARCH
- A Phase II Trial of Erlotinib in Combination with Bevacizumab in Patients with Metastatic Breast Cancer
- (2008) M. N. Dickler et al. CLINICAL CANCER RESEARCH
- Biological Processes Associated with Breast Cancer Clinical Outcome Depend on the Molecular Subtypes
- (2008) C. Desmedt et al. CLINICAL CANCER RESEARCH
- Basal-Like Breast Cancer Defined by Five Biomarkers Has Superior Prognostic Value than Triple-Negative Phenotype
- (2008) M. C.U. Cheang et al. CLINICAL CANCER RESEARCH
- Triple-Negative Breast Cancer: Risk Factors to Potential Targets
- (2008) B. P. Schneider et al. CLINICAL CANCER RESEARCH
- S100A8 and S100A9 Overexpression Is Associated with Poor Pathological Parameters in Invasive Ductal Carcinoma of the Breast
- (2008) Kazumori Arai et al. CURRENT CANCER DRUG TARGETS
- Increased expression of osteopontin in patients with triple-negative breast cancer
- (2008) X. Wang et al. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
- Basal cytokeratin expression in relation to biological factors in breast cancer
- (2008) Hajime Kuroda et al. HUMAN PATHOLOGY
- The combination of high cyclin E and Skp2 expression in breast cancer is associated with a poor prognosis and the basal phenotype
- (2008) David Voduc et al. HUMAN PATHOLOGY
- How basal are triple-negative breast cancers?
- (2008) François Bertucci et al. INTERNATIONAL JOURNAL OF CANCER
- Increased claudin-4 expression is associated with poor prognosis and high tumour grade in breast cancer
- (2008) Fiona Lanigan et al. INTERNATIONAL JOURNAL OF CANCER
- How different are luminal A and basal breast cancers?
- (2008) François Bertucci et al. INTERNATIONAL JOURNAL OF CANCER
- A Decade of Tissue Microarrays: Progress in the Discovery and Validation of Cancer Biomarkers
- (2008) Robert L. Camp et al. JOURNAL OF CLINICAL ONCOLOGY
- A Synthetic Lethal Therapeutic Approach: Poly(ADP) Ribose Polymerase Inhibitors for the Treatment of Cancers Deficient in DNA Double-Strand Break Repair
- (2008) Alan Ashworth JOURNAL OF CLINICAL ONCOLOGY
- Expression of epidermal growth factor receptor in relation to BRCA1 status, basal-like markers and prognosis in breast cancer
- (2008) J B Arnes et al. JOURNAL OF CLINICAL PATHOLOGY
- Nestin is expressed in basal-like and triple negative breast cancers
- (2008) S Parry et al. JOURNAL OF CLINICAL PATHOLOGY
- Expression of basal keratins and vimentin in breast cancers of young women correlates with adverse pathologic parameters
- (2008) Maureen Hong-Sing Chen et al. MODERN PATHOLOGY
- Secretory breast carcinomas with ETV6-NTRK3 fusion gene belong to the basal-like carcinoma spectrum
- (2008) Marick Laé et al. MODERN PATHOLOGY
- Direct multiplexed measurement of gene expression with color-coded probe pairs
- (2008) Gary K Geiss et al. NATURE BIOTECHNOLOGY
- CD109 expression in basal-like breast carcinoma
- (2008) Masaki Hasegawa et al. PATHOLOGY INTERNATIONAL
- Clinical and pathologic aspects of basal-like breast cancers
- (2008) Oluwole Fadare et al. Nature clinical practice. Oncology
- αB-crystallin: A novel marker of invasive basal-like and metaplastic breast carcinomas
- (2007) Stephanie M. Sitterding et al. Annals of Diagnostic Pathology
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started